Elite in Pseudomembranous Colitis
Check Dr. Sahil N. Khanna's experience treating your condition:
About Dr. Sahil N. Khanna

Sahil Khanna is a Gastroenterologist in Rochester, Minnesota. Khanna has been practicing medicine for over 17 years and is rated as an Elite expert by MediFind in the treatment of Pseudomembranous Colitis. He is also highly rated in 17 other conditions, according to our data. His top areas of expertise are Diarrhea, Pseudomembranous Colitis, Food Poisoning, Colonoscopy, and Ileostomy. He is licensed to treat patients in Minnesota. Khanna is currently accepting new patients.

His clinical research consists of co-authoring 209 peer reviewed articles and participating in 4 clinical trials in the past 15 years. In particular, he has co-authored 18 articles in the study of Pseudomembranous Colitis.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Sahil N. Khanna it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
200 1st St Sw, Rochester, MN 55905
Background & Education
Graduate Institution
Other, 2006
Internal Medicine in MN
Hospital Affiliations
Mayo Clinic Hospital - Saint Marys Campus
Mayo Clinic Health System - Franciscan Healthcare La Crosse
Mayo Clinic Health System - Albert Lea
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection
Fecal Microbiota Transplant National Registry
Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients
Treatment of Recurrent Clostridium Difficile Infection With RBX7455: A Dose-ranging, Prospective, Single Center, Open Label Phase I Trial
View 1 Less Clinical Trial -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors